Product Name: Alinity M Sars-Cov-2 Amp Kit (Us Eua)
Product Name: Alinity M Sars-Cov-2 Amp Kit (Us Eua)
Product Name: Alinity M Sars-Cov-2 Amp Kit (Us Eua)
Product Name
Components:
9N78P0001 Alinity m SARS-COV-2 AMP TRAY 1
09N78-090 ACT Alinity m SARS-COV-2 ACT TRAY 2
09N78-095 ACT
Abbott Customers:
For additional information, please contact your Abbott Customer Support Center Representative by calling 1-800-527-1869, 1-
800-323-9100, or 1-800-235-5396.
Abbott employees:
For additional information relative to the content of the SDSs, please contact your local Safety Representative.
Page 1/9
1 Identification
· Product name: Alinity m SARS-COV-2 AMP TRAY 1
2 Hazard(s) identification
· Classification of the substance or mixture
The classification was made according to U.S. OSHA 29 CFR 1910.1200 and 1910.1030 and applicable European
regulations, and is expanded upon from supplier company and/or literature data.
Skin Sens. 1 H317 May cause an allergic skin reaction.
· Label elements
· GHS label elements: The product is labelled according to the Globally Harmonized System (GHS).
· Hazard pictograms:
49.4.22
Page 2/9
3 Composition/information on ingredients
· Chemical characterization: Mixture of chemical and/or biological substances for in vitro diagnostic use.
· Hazardous chemical ingredients per U.S. OSHA criteria (29 CFR 1910.1200 Hazard Communication):
CAS: 77-86-1 Tris hydroxymethyl aminomethane 2.42%
CAS: 56-81-5 Glycerol 1.07%
CAS: 2682-20-4 2-Methyl-4-isothiazolin-3-one 0.015%
4 First-aid measures
· General information: Immediately remove any clothing soiled by the product.
· After inhalation: Remove from source of exposure. Seek medical attention and appropriate follow-up.
· After skin contact:
Take off any clothing that the product touched. Wash affected area with soap and water. Seek medical attention and
appropriate follow-up.
· After eye contact:
Rinse open eye(s) cautiously with water for several minutes. Remove contact lenses, if present and easy to do.
Continue rinsing. Seek medical attention and appropriate follow-up. Wash hands after handling.
· After swallowing: Rinse mouth with water. Seek medical attention and appropriate follow-up.
· Information for Medical Personnel
This product contains human sourced and/or potentially infectious components. See package insert / instructions for
use for details. No known test method can offer complete assurance that products derived from human sources or
inactivated microorganisms will not transmit infection.
· Most important symptoms and effects, both acute and delayed:
Kidney effects
Allergic reactions
USA
49.4.22
Page 3/9
5 Fire-fighting measures
· Suitable extinguishing agents
Dry chemical, carbon dioxide (CO2), water spray or regular foam.
- Caution: CO2 will displace air in confined spaces and may cause an oxygen-deficient atmosphere.
- For larger fires: There are no unique chemical or reactivity hazards that would impact firefighting decisions related
to this product. Use firefighting measures that suit the environment.
· Special hazards arising from the substance or mixture
There are no unique chemical or reactivity hazards that would impact firefighting decisions due to the chemicals in this
product.
No further relevant information available.
· Protective equipment
For large fires, wear appropriate heat- and flame-resistant personal protective equipment and a NFPA/NIOSH
approved positive-pressure, self-contained breathing apparatus.
NOTE: Commercial disinfectants must be used according to manufacturer directions. Disinfectants are typically
hazardous chemicals that react with many chemicals, materials and living tissues. Obtain and review the
manufacturer’s safety information before using the disinfectant.
USA
49.4.22
Page 4/9
Dispose of spilled and contaminated material in accordance with Federal, State, and Local regulations. See Section
13 for information that may impact disposal of materials contaminated with this product.
· Reference to other sections
See Section 7 for information on safe handling.
See Section 8 for information on personal protection equipment.
See Section 13 for disposal information.
USA
49.4.22
Page 5/9
Small-volume spills (e.g. small enough to clean up with a paper towel or small sorbent pad) - respiratory protection
should not be necessary if room is well ventilated.
Other unusual conditions (e.g. volume spilled too big to clean up with materials in arm's reach) - Use appropriate
NIOSH-approved air-purifying respirator if airborne chemical concentrations may exceed the exposure limit (if any)
listed above.
49.4.22
Page 6/9
11 Toxicological information
· Acute toxicity
· LD50/LC50 values for hazardous ingredients per OSHA criteria:
· Ingredients (100% pure substance/s):
CAS: 77-86-1 Tris hydroxymethyl aminomethane
Oral LD50 5,900 mg/kg (rat)
LDLo 1,000 mg/kg (rabbit)
CAS: 56-81-5 Glycerol
Oral LD50 4,090 mg/kg (mammal)
TDLo (Other effects) 1,428 mg/kg (human)
Reported headaches, nausea and vomiting.
Dermal LD50 >10,000 mg/kg (rabbit)
Inhalation LC50 1 h 0.57 mg/l (Rat)
Mutagenicity (Ames Assay)
CAS: 2682-20-4 2-Methyl-4-isothiazolin-3-one
Oral LD50 60 mg/kg (mouse)
By analogy to methylchloroisothiazolinone.
53 mg/kg (rat)
By analogy to methylchloroisothiazolinone.
· Primary toxicological effects of the final product:
· Skin irritation: No irritant effect.
· Eye irritation: No irritant effect.
USA
49.4.22
Page 7/9
12 Ecological information
· Aquatic toxicity:
CAS: 2682-20-4 2-Methyl-4-isothiazolin-3-one
LC50 96 h 0.19 mg/l (trout) (Flow through)
LC50 48 h (Static) 0.056 mg/l (other) (Crustacean - Acartia tonsa)
· Additional ecological information
· General notes:
Do not allow undiluted product or large quantities of it to reach ground water, water course, or sewage system.
· Results of PBT and vPvB assessment
· PBT: Not applicable
· vPvB: Not applicable
13 Disposal considerations
· Recommendation for disposal of unused product:
Dispose in accordance with federal, state and local regulations and institutional requirements. The following may
be particularly important when identifying appropriate disposal:
- Potentially infectious. See Section 4, Information for Medical Personnel, for more information.
- See Section 6 for information when institutional or regulatory requirements include any sort of treatment of
potentially infectious waste.
· Recommendation for disposal of packaging:
Non-contaminated packaging may be used for recycling. Refer to applicable local regulations and institutional
policies.
For disposal of contaminated packaging, refer to applicable local regulations and institutional policies.
USA
49.4.22
Page 8/9
14 Transport information
· DOT, ADN, IMDG, IATA none
· UN proper shipping name
· DOT, ADN, IMDG, IATA none
· Transport hazard class(es)
· DOT, ADN, IMDG, IATA
· Class none
· DOT, IMDG, IATA none
· Environmental hazards
· Marine pollutant: No
· Additional information
· DOT
· Remarks: Not restricted for transportation.
· IMDG
· Remarks: Not restricted for transportation.
· IATA
· Remarks: Not restricted for transportation.
15 Regulatory information
· SARA (Superfund Amendments and Reauthorization Act of 1986 - USA):
· Section 302/304 (40CFR355.30 / 40CFR355.40):
CAS: 7647-01-0 hydrochloric acid
· Section 313 (40CFR372.65):
CAS: 7647-01-0 hydrochloric acid
· Hazardous Air Pollutants
CAS: 7647-01-0 hydrochloric acid
· California Proposition 65 (USA):
· Chemicals known to cause cancer:
The product does not contain listed substances.
· Chemicals known to cause female reproductive toxicity:
None of the ingredients is listed.
· Chemicals known to cause male reproductive toxicity:
None of the ingredients is listed.
USA
49.4.22
Page 9/9
16 Other information
The information and recommendations contained herein are based upon information or tests believed to be reliable.
Abbott Laboratories does not guarantee the accuracy or completeness of this information or recommendations
contained herein, NOR SHALL ANY OF THIS INFORMATION CONSTITUTE A WARRANTY, WHETHER
EXPRESSED OR IMPLIED, AS TO THE SAFETY OF THE GOODS, THE MERCHANTABILITY OF THE GOODS, OR
THE FITNESS OF THE GOODS FOR A PARTICULAR PURPOSE.
This information is not a substitute for the advice of a health care professional, nor is it a recommendation for any
particular course of treatment. It is not intended to supplement, modify or supersede any information (e.g. labeling and
package inserts) provided with respect to the medical use of the product. Abbott Laboratories assumes no
responsibility for results obtained or for incidental or consequential damages, including lost profits, arising from the use
of these data. No warranty against infringement of any patent, copyright or trademark is made or implied.
· Department issuing SDS
- Abbott Diagnostics Safety, Health and Environmental Assurance
Department 0571
· Contact
Tel. Abbott Molecular Customer Service: 1-800-553-7042
- General information about this product:
Abbott Diagnostics
Technical Support
100 Abbott Park Road
Abbott Park, IL 60064-3500
· * Sections marked with an asterisk (*) have been altered since the previous version.
USA
49.4.22
Page 1/9
1 Identification
· Product name: Alinity m SARS-COV-2 ACT TRAY 2
* 2 Hazard(s) identification
· Classification of the substance or mixture
The classification was made according to U.S. OSHA 29 CFR 1910.1200 and 1910.1030 and applicable European
regulations, and is expanded upon from supplier company and/or literature data.
Acute Tox. 4 H302 Harmful if swallowed.
Skin Sens. 1 H317 May cause an allergic skin reaction.
STOT SE 1 H370 Causes damage to organs.
Aquatic Chronic 3 H412 Harmful to aquatic life with long lasting effects.
· Label elements
· GHS label elements: The product is labelled according to the Globally Harmonized System (GHS).
· Hazard pictograms:
49.4.22
Page 2/9
3 Composition/information on ingredients
· Chemical characterization: Mixture of chemical and/or biological substances for in vitro diagnostic use.
· Hazardous chemical ingredients per U.S. OSHA criteria (29 CFR 1910.1200 Hazard Communication):
CAS: 75-57-0 Tetramethylammonium chloride 8.71%
CAS: 2682-20-4 2-Methyl-4-isothiazolin-3-one 0.015%
4 First-aid measures
· General information: Immediately remove any clothing soiled by the product.
· After inhalation: Remove from source of exposure. If irritation or signs of toxicity occur, seek medical attention.
· After skin contact:
Take off any clothing that the product touched.
Rinse skin with running water for 15 to 20 minutes. Seek medical attention if irritation or signs of toxicity occur.
· After eye contact:
Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
If eye irritation persists, get medical advice/attention. Wash hands after handling.
· After swallowing: Rinse mouth with water. If irritation or signs of toxicity occur, seek medical attention.
· Information for Medical Personnel
· Most important symptoms and effects, both acute and delayed:
Allergic reactions
USA
49.4.22
Page 3/9
5 Fire-fighting measures
· Suitable extinguishing agents
Dry chemical, carbon dioxide (CO2), water spray or regular foam.
- Caution: CO2 will displace air in confined spaces and may cause an oxygen-deficient atmosphere.
- For larger fires: There are no unique chemical or reactivity hazards that would impact firefighting decisions related
to this product. Use firefighting measures that suit the environment.
· Special hazards arising from the substance or mixture
There are no unique chemical or reactivity hazards that would impact firefighting decisions due to the chemicals in this
product.
No further relevant information available.
· Protective equipment
For large fires, wear appropriate heat- and flame-resistant personal protective equipment and a NFPA/NIOSH
approved positive-pressure, self-contained breathing apparatus.
49.4.22
Page 4/9
Small-volume spills (e.g. small enough to clean up with a paper towel or small sorbent pad) - respiratory protection
should not be necessary if room is well ventilated.
Other unusual conditions (e.g. volume spilled too big to clean up with materials in arm's reach) - Use appropriate
NIOSH-approved air-purifying respirator if airborne chemical concentrations may exceed the exposure limit (if any)
listed above.
49.4.22
Page 5/9
· Body protection:
Normal use: protect personal clothing from spatters and small spills. Wear a laboratory coat (or other protective
clothing required by your institution).
Larger spills (e.g. that can saturate cloth): wear appropriate water-repellant covering over clothing.
49.4.22
Page 6/9
11 Toxicological information
· Acute toxicity
· LD50/LC50 values for hazardous ingredients per OSHA criteria:
· Ingredients (100% pure substance/s):
CAS: 75-57-0 Tetramethylammonium chloride
Oral LD50 50 mg/kg (rat)
National Technical Information Service. Vol. OTS0536975
Sources cited: Toxicological Data, compiled by the National Institute of Health (NIH), USA, selected and
distributed by Technical Database Services (TDS), New York, 2009
CAS: 2682-20-4 2-Methyl-4-isothiazolin-3-one
Oral LD50 60 mg/kg (mouse)
By analogy to methylchloroisothiazolinone.
53 mg/kg (rat)
By analogy to methylchloroisothiazolinone.
· Primary toxicological effects of the final product:
· Skin irritation: No irritant effect.
· Eye irritation: No irritant effect.
· Sensitization: Sensitization possible through skin contact.
· Additional toxicological information: None
· Carcinogenic categories
· IARC (International Agency for Research on Cancer)
None of the ingredients is listed.
· NTP (National Toxicology Program)
None of the ingredients is listed.
· OSHA-Ca (Occupational Safety & Health Administration)
None of the ingredients is listed.
· Target organs/systems:
Skin
Immune system
12 Ecological information
· Aquatic toxicity:
CAS: 75-57-0 Tetramethylammonium chloride
LC50 96 h 462 mg/l (minnow)
Source cited: Ecotoxicological Data, compiled by the US Environmental Protection Agency (EPA),
selected and distributed by Technical Database Services (TDS), New York, 2009
USA
49.4.22
Page 7/9
13 Disposal considerations
· Recommendation for disposal of unused product:
Dispose in accordance with federal, state and local regulations.
· Recommendation for disposal of packaging:
Non-contaminated packaging may be used for recycling. Refer to applicable local regulations and institutional
policies.
For disposal of contaminated packaging, refer to applicable local regulations and institutional policies.
· Recommended cleansing agent: Water with cleansing agents, if necessary.
14 Transport information
· DOT, ADN, IMDG, IATA none
· UN proper shipping name
· DOT, ADN, IMDG, IATA none
· Transport hazard class(es)
· DOT, ADN, IMDG, IATA
· Class none
· DOT, IMDG, IATA none
· Environmental hazards
· Marine pollutant: No
· Additional information
· DOT
· Remarks: Not restricted for transportation.
· IMDG
· Remarks: Not restricted for transportation.
USA
49.4.22
Page 8/9
· IATA
· Remarks: Not restricted for transportation.
15 Regulatory information
· SARA (Superfund Amendments and Reauthorization Act of 1986 - USA):
· Section 302/304 (40CFR355.30 / 40CFR355.40):
The product does not contain listed substances.
· Section 313 (40CFR372.65):
The product does not contain listed substances.
· Hazardous Air Pollutants
None of the ingredients is listed.
· California Proposition 65 (USA):
· Chemicals known to cause cancer:
The product does not contain listed substances.
· Chemicals known to cause female reproductive toxicity:
None of the ingredients is listed.
· Chemicals known to cause male reproductive toxicity:
None of the ingredients is listed.
· Chemicals known to cause developmental reproductive toxicity:
None of the ingredients is listed.
16 Other information
The information and recommendations contained herein are based upon information or tests believed to be reliable.
Abbott Laboratories does not guarantee the accuracy or completeness of this information or recommendations
contained herein, NOR SHALL ANY OF THIS INFORMATION CONSTITUTE A WARRANTY, WHETHER
EXPRESSED OR IMPLIED, AS TO THE SAFETY OF THE GOODS, THE MERCHANTABILITY OF THE GOODS, OR
THE FITNESS OF THE GOODS FOR A PARTICULAR PURPOSE.
This information is not a substitute for the advice of a health care professional, nor is it a recommendation for any
particular course of treatment. It is not intended to supplement, modify or supersede any information (e.g. labeling and
package inserts) provided with respect to the medical use of the product. Abbott Laboratories assumes no
responsibility for results obtained or for incidental or consequential damages, including lost profits, arising from the use
of these data. No warranty against infringement of any patent, copyright or trademark is made or implied.
· Department issuing SDS
- Abbott Diagnostics Safety, Health and Environmental Assurance
Department 0571
· Contact
Tel. Abbott Molecular Customer Service: 1-800-553-7042
- General information about this product:
Abbott Diagnostics
Technical Support
USA
49.4.22
Page 9/9
· * Sections marked with an asterisk (*) have been altered since the previous version.
USA
49.4.22